🔴 Park Ha Biological Technology is trading 5.8% down in pre-market with no confirmed catalyst

Park Ha Biological Technology is trading 5.8% down in pre-market at $3.25, with the reason unconfirmed and no new company-specific announcement, earnings release, or regulatory catalyst identified for August 11.

• Nasdaq’s corporate-action notice concerns the previously announced 1-for-8 reverse split, effective August 6, not a new event.
• Recent volatility follows the reverse split and disclosed equity issuances, including a private placement and potential warrant dilution.
• The broader market is only modestly weaker, so macro sentiment does not clearly explain the decline.